Maria Gisella Cavallo

Pubblicazioni

Titolo Pubblicato in Anno
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study DIABETES, OBESITY AND METABOLISM 2024
Neurotensin: Linking metabolism and cardiovascular disease ATHEROSCLEROSIS 2024
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes DIABETES/METABOLISM RESEARCH AND REVIEWS 2023
A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2023
Dynamic Changes of BVRA Protein Levels Occur in Response to Insulin: A Pilot Study in Humans INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease HEPATOLOGY INTERNATIONAL 2023
Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2023
Neurotensin Gene rs2234762 C>G Variant Associates with Reduced Circulating Pro-NT Levels and Predicts Lower Insulin Resistance in Overweight/Obese Children INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Reduced High-Density Lipoprotein Cholesterol Is an Independent Determinant of Altered Bone Quality in Women with Type 2 Diabetes INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Short-term effectiveness of dapagliflozin versus {DPP}-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023
Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study DIABETES, OBESITY AND METABOLISM 2023
Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Validation in type 2 diabetes of a metabolomic signature of all-cause mortality DIABETES/METABOLISM RESEARCH AND REVIEWS 2023
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus CARDIOVASCULAR DIABETOLOGY 2023
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus DIABETES & METABOLISM 2023
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus DIABETES & METABOLISM 2023
Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes ACTA DIABETOLOGICA 2022
CAPTURE: A cross-sectional study on the prevalence of cardiovascular disease in adults with type 2 diabetes in Italy NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2022
New Insights in the Control of Fat Homeostasis: The Role of Neurotensin INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Deep Resequencing of 9 Candidate Genes Identifies a Role for ARAP1 and IGF2BP2 in Modulating Insulin Secretion Adjusted for Insulin Resistance in Obese Southern Europeans INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma